Cargando…
Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management
Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown. Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Ev...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326508/ https://www.ncbi.nlm.nih.gov/pubmed/34350199 http://dx.doi.org/10.3389/fmed.2021.700014 |
_version_ | 1783731841600061440 |
---|---|
author | Xiong, Xiaomo Yuan, Jing Li, Minghui Jiang, Bin Lu, Z. Kevin |
author_facet | Xiong, Xiaomo Yuan, Jing Li, Minghui Jiang, Bin Lu, Z. Kevin |
author_sort | Xiong, Xiaomo |
collection | PubMed |
description | Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown. Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Event Reporting System (VAERS) from December 14, 2020, through January 22, 2021. We compared the top 10 AEs, serious AEs, along with office and emergency room (ER) visits by age (18–64 years, ≥65 years) and gender (female, male). Results: There were age and gender disparities among adults with AEs following COVID-19 vaccination. Compared to younger adults aged between 18 and 64 years, older adults were more likely to report serious AEs, death, permanent disability, and hospitalization. Males were more likely to report serious AEs, death, and hospitalization compared to females. Conclusions: COVID-19 vaccines are generally safe but possible age and gender disparities in reported AEs may exist. |
format | Online Article Text |
id | pubmed-8326508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83265082021-08-03 Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management Xiong, Xiaomo Yuan, Jing Li, Minghui Jiang, Bin Lu, Z. Kevin Front Med (Lausanne) Medicine Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown. Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Event Reporting System (VAERS) from December 14, 2020, through January 22, 2021. We compared the top 10 AEs, serious AEs, along with office and emergency room (ER) visits by age (18–64 years, ≥65 years) and gender (female, male). Results: There were age and gender disparities among adults with AEs following COVID-19 vaccination. Compared to younger adults aged between 18 and 64 years, older adults were more likely to report serious AEs, death, permanent disability, and hospitalization. Males were more likely to report serious AEs, death, and hospitalization compared to females. Conclusions: COVID-19 vaccines are generally safe but possible age and gender disparities in reported AEs may exist. Frontiers Media S.A. 2021-07-19 /pmc/articles/PMC8326508/ /pubmed/34350199 http://dx.doi.org/10.3389/fmed.2021.700014 Text en Copyright © 2021 Xiong, Yuan, Li, Jiang and Lu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Xiong, Xiaomo Yuan, Jing Li, Minghui Jiang, Bin Lu, Z. Kevin Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management |
title | Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management |
title_full | Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management |
title_fullStr | Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management |
title_full_unstemmed | Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management |
title_short | Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management |
title_sort | age and gender disparities in adverse events following covid-19 vaccination: real-world evidence based on big data for risk management |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326508/ https://www.ncbi.nlm.nih.gov/pubmed/34350199 http://dx.doi.org/10.3389/fmed.2021.700014 |
work_keys_str_mv | AT xiongxiaomo ageandgenderdisparitiesinadverseeventsfollowingcovid19vaccinationrealworldevidencebasedonbigdataforriskmanagement AT yuanjing ageandgenderdisparitiesinadverseeventsfollowingcovid19vaccinationrealworldevidencebasedonbigdataforriskmanagement AT liminghui ageandgenderdisparitiesinadverseeventsfollowingcovid19vaccinationrealworldevidencebasedonbigdataforriskmanagement AT jiangbin ageandgenderdisparitiesinadverseeventsfollowingcovid19vaccinationrealworldevidencebasedonbigdataforriskmanagement AT luzkevin ageandgenderdisparitiesinadverseeventsfollowingcovid19vaccinationrealworldevidencebasedonbigdataforriskmanagement |